Literature DB >> 29599189

Pharmacokinetics of tuberculosis drugs in HIV-infected patients from Irkutsk, Russian Federation: redefining drug activity.

Galina Lyles1, Oleg Ogarkov2,3,4, Svetlana Zhdanova2, Charles A Peloquin5, Andrew Ebers6, Herman Pfaeffle7, Mohammad H Al-Shaer5, Elena Moiseeva4, Elena Zorkaltseva3,4, Mikhail Koscheev4, Eric R Houpt6, Scott K Heysell6.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29599189      PMCID： PMC6230247          DOI： 10.1183/13993003.00109-2018

Source DB:  PubMed          Journal:  Eur Respir J        ISSN： 0903-1936            Impact factor:   16.671


× No keyword cloud information.
  14 in total

1.  Low isoniazid concentrations and outcome of tuberculosis treatment with once-weekly isoniazid and rifapentine.

Authors:  Marc Weiner; William Burman; Andrew Vernon; Debra Benator; Charles A Peloquin; Awal Khan; Stephen Weis; Barbara King; Nina Shah; Thomas Hodge
Journal:  Am J Respir Crit Care Med       Date:  2003-01-16       Impact factor: 21.405

2.  Therapeutic drug monitoring to prevent acquired drug resistance of fluoroquinolones in the treatment of tuberculosis.

Authors:  Lina Davies Forsman; Judith Bruchfeld; Jan-Willem C Alffenaar
Journal:  Eur Respir J       Date:  2017-04-26       Impact factor: 16.671

Review 3.  Therapeutic drug monitoring in the treatment of tuberculosis: an update.

Authors:  Abdullah Alsultan; Charles A Peloquin
Journal:  Drugs       Date:  2014-06       Impact factor: 9.546

4.  Isoniazid clearance is impaired among human immunodeficiency virus/tuberculosis patients with high levels of immune activation.

Authors:  Christopher Vinnard; Shruthi Ravimohan; Neo Tamuhla; Vijay Ivaturi; Jotam Pasipanodya; Shashikant Srivastava; Chawangwa Modongo; Nicola M Zetola; Drew Weissman; Tawanda Gumbo; Gregory P Bisson
Journal:  Br J Clin Pharmacol       Date:  2016-12-09       Impact factor: 4.335

5.  Serum drug concentrations predictive of pulmonary tuberculosis outcomes.

Authors:  Jotam G Pasipanodya; Helen McIlleron; André Burger; Peter A Wash; Peter Smith; Tawanda Gumbo
Journal:  J Infect Dis       Date:  2013-07-29       Impact factor: 5.226

Review 6.  Individualizing management of extensively drug-resistant tuberculosis: diagnostics, treatment, and biomarkers.

Authors:  Jan-Willem C Alffenaar; Onno W Akkerman; Richard M Anthony; Simon Tiberi; Scott Heysell; Martin P Grobusch; Frank G Cobelens; Dick Van Soolingen
Journal:  Expert Rev Anti Infect Ther       Date:  2016-10-24       Impact factor: 5.091

7.  Cavitary penetration of levofloxacin among patients with multidrug-resistant tuberculosis.

Authors:  Russell R Kempker; Aline B Barth; Sergo Vashakidze; Ketino Nikolaishvili; Irina Sabulua; Nestani Tukvadze; Nino Bablishvili; Shota Gogishvili; Ravi Shankar P Singh; Jeannette Guarner; Hartmut Derendorf; Charles A Peloquin; Henry M Blumberg
Journal:  Antimicrob Agents Chemother       Date:  2015-03-16       Impact factor: 5.191

8.  HIV coinfection in multidrug- and extensively drug-resistant tuberculosis results in high early mortality.

Authors:  Neel R Gandhi; N Sarita Shah; Jason R Andrews; Venanzio Vella; Anthony P Moll; Michelle Scott; Darren Weissman; Claudio Marra; Umesh G Lalloo; Gerald H Friedland
Journal:  Am J Respir Crit Care Med       Date:  2009-10-15       Impact factor: 21.405

9.  Undertreated HIV and drug-resistant tuberculosis at a referral hospital in Irkutsk, Siberia.

Authors:  S K Heysell; O B Ogarkov; S Zhdanova; E Zorkaltseva; S Shugaeva; J Gratz; S Vitko; E D Savilov; M E Koshcheyev; E R Houpt
Journal:  Int J Tuberc Lung Dis       Date:  2016-02       Impact factor: 2.373

10.  Quantitative drug-susceptibility in patients treated for multidrug-resistant tuberculosis in Bangladesh: implications for regimen choice.

Authors:  Scott K Heysell; Shahriar Ahmed; Sara Sabrina Ferdous; Md Siddiqur Rahman Khan; S M Mazidur Rahman; Jean Gratz; Md Toufiq Rahman; Asif Mujtaba Mahmud; Eric R Houpt; Sayera Banu
Journal:  PLoS One       Date:  2015-02-24       Impact factor: 3.240
View more
  1 in total

1.  Urine colorimetry for levofloxacin pharmacokinetics and personalized dosing in people with drug-resistant tuberculosis.

Authors:  Prakruti Rao; Svetlana Zhdanova; Oleg Ogarkov; Elizaveta Orlova; Andrew Ebers; Suzanne Stroup; Shino Mirawdaly; Daniel Van Aartsen; Olga Koshkina; Alexey Suzdalnitsky; Elena Moiseeva; Rebecca Dillingham; Scott K Heysell
Journal:  Int J Mycobacteriol       Date:  2020 Oct-Dec
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.